U.S. markets closed

  • S&P Futures

    4,261.50
    +5.50 (+0.13%)
     

  • Dow Futures

    34,218.00
    +136.00 (+0.40%)
     

  • Nasdaq Futures

    14,358.50
    +4.25 (+0.03%)
     

  • Russell 2000 Futures

    2,334.40
    +3.20 (+0.14%)
     

  • Crude Oil

    73.34
    +0.04 (+0.05%)
     

  • Gold

    1,777.50
    +0.80 (+0.05%)
     

  • Silver

    26.12
    +0.07 (+0.27%)
     

  • EUR/USD

    1.1945
    +0.0010 (+0.08%)
     

  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     

  • Vix

    15.97
    -0.35 (-2.14%)
     

  • GBP/USD

    1.3933
    +0.0012 (+0.08%)
     

  • USD/JPY

    110.8770
    +0.0420 (+0.04%)
     

  • BTC-USD

    35,001.28
    +2,412.63 (+7.40%)
     

  • CMC Crypto 200

    843.24
    +56.62 (+7.20%)
     

  • FTSE 100

    7,109.97
    +35.91 (+0.51%)
     

  • Nikkei 225

    29,093.00
    +217.77 (+0.75%)
     

ClareMedica Health Partners CEO, Roberto L. Palenzuela, Invited to Participate as a Tripletree “Market Insights Live” Panelist

·1 min read

MIAMI, FL / ACCESSWIRE / June 24, 2021 / ClareMedica Health Partners, LLC ("ClareMedica") one of Florida's premier health care organizations focused on the delivery of primary care to seniors, announced today that the company's chief executive officer, Roberto L. Palenzuela, has been invited to participate as a TripleTree Market Insights Live panelist on June 29, 2021, at 11:00 a.m. Eastern.

Mr. Palenzuela will be discussing various aspects of the health care industry on a guest panel entitled "21st Century Primary Care" with a particular focus on the future of primary care and technology enabled solutions that will aid in its delivery.

The TripleTree Market Insights Live is virtual presentation and registration to attend is available by visiting: https://register.gotowebinar.com/register/396203932602044942?source=Web

About ClareMedica Health Partners

ClareMedica is a growing health care company that provides and coordinates comprehensive health care services for Medicare Advantage, Medicaid, and other customers through a network of employed and affiliated physicians. We deliver accountable care for all health care stakeholders by employing a patient-centric care model that adds value and provides solutions for a changing health care industry. With multiple locations in Central and South Florida, our health care network has over 100 providers and continues to grow. To learn more about ClareMedica Health Partners, LLC, please visit the company's website at www.claremedica.com.

Contacts:

Al Palombo
Chief Marketing Officer
ClareMedica Health Partners, LLC
(786) 758-3133
albert@claremedica.com

SOURCE: ClareMedica Health Partners, LLC



View source version on accesswire.com:
https://www.accesswire.com/653076/ClareMedica-Health-Partners-CEO-Roberto-L-Palenzuela-Invited-to-Participate-as-a-Tripletree-Market-Insights-Live-Panelist

Recommended Stories

  • Sorrento Is Firing on All Cylinders

    Sorrento Therapeutics (SRNE) is a company with its foot on the gas, and hardly a week goes by without new developments. This week is no different. On Tuesday, the biotech announced a multi-year Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Research Unit (NAMRU-3). The partnership’s aim is to conduct infectious disease research that assists the Department of Defense (DoD), informs host nation partners’ public health policy, and improves the U.S. Armed Forces m

  • Lilly to seek FDA approval for potential Alzheimer’s drug later this year

    Eli Lilly is nearly ready to take another shot at getting approval for a possible Alzheimer’s drug. The drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year. The announcement comes a few weeks after the FDA approved a treatment from rival Biogen, despite warnings from the agency’s independent advisers that it hasn’t been shown to help slow the brain-destroying disease.

  • ‘Unchecked spread in the U.S. is going to lead to other problems’: Doctor

    Dr. Anand Swaminathan, Emergency Medicine Physician in New Jersey, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

  • If This Animal Is Acting Overly Friendly, Call Authorities, Experts Say

    From birds to butterflies to bunnies, summer is peak season for outdoor animal watching. And while certain wildlife may be welcome sights in your backyard, there's one common animal that experts want you to be particularly cautious around right now due to the serious threat they may pose.However, it's not just aggressive behavior from this animal you have to watch out for—if this animal is acting friendly to you, it's time to call the authorities. Read on to find out how to best protect yourself

  • Ashley Graham turns up the ‘heat’ in blue bra and underwear set

    The 33-year-old model can pull over any color.

  • Rite Aid CEO: Our vaccine rollout was much bigger than expected

    Rite Aid “never thought [it] would get inundated with people trying to get a vaccine,” CEO of Rite Aid (RAD) Heyward Donigan said in a discussion panel as part of the Milken Institute’s Future of Health Summit.

  • The CDC Isn’t Convinced Yet That Covid-19 Boosters Are Required. What It Means for Vaccine Stocks.

    The CDC discussed the evidence for Covid-19 vaccine boosters, but suggested that data did not yet support a recommendation.

  • Top Healthcare Stocks for July 2021

    These are the healthcare stocks with the best value, fastest growth, and most momentum for July 2021.

  • If You Got Pfizer or Moderna, the FDA Has a New Warning For You

    Even though nearly 178 million people in the U.S. have already gotten at least one shot of a COVID vaccine, the vaccine rollout in the U.S. has had some bumps along the way. One of the three vaccines available, Johnson&Johnson, was put on a temporary hold after health experts began to see cases of blood clots after vaccination. Once the vaccine was taken off its pause, the U.S. Food and Drug Administration (FDA) had to add a warning about the potential for blood clots following Johnson&Johnson v

  • Countries that relied on Chinese vaccines see renewed COVID-19 surges

    Countries that relied on Chinese-manufactured coronavirus vaccines are experiencing a surge in cases, suggesting the shots may not be effective at stopping the spread of new infections, particularly those caused by highly transmissible variants.

  • Why Eli Lilly Stock Is Up By 8% Today

    The stock made an attempt to settle above $239.

  • ‘Vaccination is very effective against the Delta variant’: Doctor

    Dr. Shereef Elnahal, University Hospital CEO and former NJDOH Commissioner, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

  • Entera Bio Surging on Drug Development; Will the Rise Continue?

    Entera Bio Ltd.'s (ENTX) share price surged 44.8% to close at $6.50 on June 23. Entera Bio is a developer of orally delivered large molecule and biologic therapeutics. The company continues to witness developments and improvements in drug research in 2021, winning the confidence of its investors and seeing its share price rise to a new high. With a market capital of 154.5 million, the share price of Entera Bio has almost tripled recently. It has skyrocketed 507.5% and 233.3% over the past six mo

  • mRNA vaccine-makers’ stocks take a hit amid possible link to rare heart conditions

    There could be a 'likely association' between adolescents getting the vaccines and cases of myocarditis and pericarditis.

  • 'Single most qualified' mRNA expert speaks about vaccine risks after he says YouTube banned his video

    The man who invented the mRNA technology used in some coronavirus vaccines says he was censored by YouTube for sharing his concerns on the vaccines in a podcast.

  • Sydney Residents in Lockdown: Biden Says Get Shots: Virus Update

    (Bloomberg) -- More than 500,000 residents of Sydney will go into lockdown for at least a week as Australia races to control an outbreak of the highly transmissible delta variant of the coronavirus. President Joe Biden warned of the risks posed by the delta variant as he prodded Americans to get vaccinated amid a decline in the pace of inoculations.India this week hit a single-day record by administering more than 8 million Covid-19 vaccinations -- but even this unprecedented pace may not be fas

  • Expect wave of severe health problem diagnoses: Labcorp CEO

    The coronavirus pandemic will leave long-lasting issues for Americans across the country, even those who might not know it yet.

  • Is Subway selling real tuna or is it fake? Test finds no tuna DNA.

    After a class-action lawsuit was filed against Subway in January alleging that its tuna was fake, the New York Times launched an investigation.

  • Oxford researchers say they developed COVID vaccine efficacy predictor

    Researchers at Oxford University said Thursday they developed a method for predicting the efficacy of coronavirus vaccines by a blood test.Why it matters: The model "can be used to extrapolate efficacy estimates for new vaccines where large efficacy trials cannot be conducted," the researchers said in their paper, which was submitted for peer review for publication in a scientific journal on Thursday.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for

  • Covid-19 Test Positivity Rate, A Key Indicator Of Infections, Steadily Rising In California

    For the first time since December 2020, California’s 7-day Covid test positivity rate is on the rise. The test positivity rate, which hit a pandemic-era low of 0.7% on June 5, has risen slowly but steadily over the past two-and-a-half weeks to 1.1% on Wednesday. It’s the first sustained rise in that key Covid-19 indicator […]